Herzkrankheiten pp 1398-1409 | Cite as


  • N. Kröger
  • H. Frenzel


Durch die Verminderung des Herzzeitvolumens werden nervale und neurohumorale Mechanismen in Gang gesetzt, die über Erhöhung des peripheren Widerstands und über vermehrte Salz- und Wasserretention den systemischen Blutdruck, das Plasmavolumen und damit das Herzzeitvolumen steigern sollen. Für die Ödempathogenese entscheidend ist die vermehrte Salz- und Wasserretention der Niere.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ames RP (1986) The effects of antihypertensive drugs on serumlipids and lipoproteins. Drugs 32:260PubMedCrossRefGoogle Scholar
  2. Atlas SA, Laragh JH (1986) Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis. Ann Rev Med 37:397PubMedCrossRefGoogle Scholar
  3. Auld RB, Alexander EA, Levinsky NG (1971) Proximal tubular function in dogs with thoracic cavai constriction. J Clin Invest SO:2150Google Scholar
  4. Baba WI, Lant AF, Smith AJ, Townshend MM, Wilson GM (1968) Pharmacological effects in animals and normal human subjects of diuretic amiloride hydrochloride. Clin Pharmacol Ther 9:318PubMedGoogle Scholar
  5. Badr KF, Ichikawa I (1988) Prerenal failure: a deleterious shift form renal compensation to decompen-sation. N Engl J Med 319:623PubMedCrossRefGoogle Scholar
  6. Bayliss J, Norell M, Canepa-Anson R et al. (1987) Untreated heart failure. Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57:17PubMedCrossRefGoogle Scholar
  7. Brater DC, Chennvasin P, Seiwell R (1986) Furosemide in patients with heart failure. Shift of the dose-response relationship. Clin Pharmacol Ther 28:182CrossRefGoogle Scholar
  8. Bull MB, Laragh JH (1968) A potassium spring natriuretic agent. Circulation 37:45PubMedGoogle Scholar
  9. Bello-Reuss E (1980) Effect of catecholamines on fluid reabsorption by the isolated proximal convoluted tubule. Am J Physiol 238:347Google Scholar
  10. Bennet WM, Bagby UC (1973) Antenovic JN, Porter GA (1973) Influence of volume expansion on proximal tubular sodium reabsorption in congestive heart failure. Am Heart J 85:55CrossRefGoogle Scholar
  11. Brooks DP, Share L, Crofton JT (1986) Central adrenergic control of vasopressin release. Neuroendocrinology 42:416PubMedCrossRefGoogle Scholar
  12. Cirksena WJ, Dirks JH, Berliner RW (1966) Effect of thoracic cava obstruction on response of proximal tubule sodium reabsorption to saline infusion. J Clin Invest 45:276CrossRefGoogle Scholar
  13. Cogan MG (1990) Atrial natriuretic peptide. Kidney Intern 37(4): 1148CrossRefGoogle Scholar
  14. Cohn JN, Levine TB, Olivari MT et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819PubMedCrossRefGoogle Scholar
  15. Di Bona GF (1977) Neurogenic regulation of renal tubular sodium reabsorption. Am J Physiol 223:173Google Scholar
  16. Dagie HJ, Cleland JFG, Leckie BJ et al (1987) Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 75 (Suppl IV):98Google Scholar
  17. Dzau VJ, Packer M, Lilly LS et al (1984) Prostaglandins in severe congestive heart failure. N Engl J Med 310:347PubMedCrossRefGoogle Scholar
  18. Dzau VJ, Swartz SL, Creager MA (1986) Role or prostaglandins in the pathophysiology and therapy of congestive heart failure. Heart failure 2:3Google Scholar
  19. Dzau VJ (1987) Renal and circulatory mechanisms in congestive heart failure. Kidney Int 31:1402PubMedCrossRefGoogle Scholar
  20. Ellison DH, Velazquez H, Wright FS (1989) Adaption of the distal convoluted tubule of the rat. Structural and functional effect of the dietary salt intake and chronic diuretic infusion. J Clin Invest 83:113PubMedCrossRefGoogle Scholar
  21. Fanestil DD (1988) Mechanism of action of aldosterone blockers. Semin Nephrol 8:249PubMedGoogle Scholar
  22. Fernandez PC, Puschett JB (1973) Proximal tubular actions of metolazone and chlorothiazide. Am J Physiol 225:954PubMedGoogle Scholar
  23. Forrester TM, Schirriffs GG (1965) Furosemide and bendrofluazide in healthy subjects. Lancet 1:409PubMedCrossRefGoogle Scholar
  24. Forsell G, Nordlander R, Orinius E (1980) Treatment of dilutional hyponatremia in congestive heart failure. Acta Med Scand 207:279CrossRefGoogle Scholar
  25. Gauer OH, Henry JP, Behn C (1970) The regulation of extracellular fluid volume. Annu Rev Physiol 32:547PubMedCrossRefGoogle Scholar
  26. Götz KI (1991) Renal natriuretic peptide and atriopeptin. Am J Physiol 261:921Google Scholar
  27. Goldberg LI, Raifer SI (1985) Dopamin receptors: Applications in clinical cardiology. Circulation 72:245PubMedCrossRefGoogle Scholar
  28. Goldberg M, Beck LH, Puschett JB, Schubert JJ (1973) Site of action of benzothiadiazines, frusemide nad ethacrynic acid. In: Lant, Wilson (eds) Modern diuretic therapy in the treatment of cardiovascular and renal disease. Excerpta Medica Amsterdam, p 135Google Scholar
  29. Goldmann AI, Steele BW, Schnaper HW et al (1980) Serum lipoprotein level during chlorthalidone therapy-a Veteran Administration-National Heart, Lung and Blood Institute cooperative study of antihypertensive therapy. JAMA 244:1691CrossRefGoogle Scholar
  30. Gottlieb SS (1989) Importance of magnesium in congestive heart failure. Am J Cardiol 63:396CrossRefGoogle Scholar
  31. Greger R, Schlatter E (1983) Cellular mechanism of the action of loop diuretics on the thick ascending limb of the henleloop. Klin Wschr 61:1019PubMedCrossRefGoogle Scholar
  32. Greger R, Wangemann P (1987) Loop diuretics. Renal Physiol 10:174PubMedGoogle Scholar
  33. Greven J, Farjam A (1990) Characterization of the renal effects of xipamide in rats. In: Proceedings of the 3rd International conference on diuretics, Mexico City 1989. Elsevier, New YorkGoogle Scholar
  34. Guignard JP, Peters G (1970) Effects of triamteren and amiloride on urinary acidification and potassium excretion in the rat. Eur J Pharmacol 10:255PubMedCrossRefGoogle Scholar
  35. Hamyln JM, Blaustein MP, Bova S et al (1991) Identification and characterization of a ouabain-like compound from human plasma. Poe Nat Acad Sci USA 88:6259CrossRefGoogle Scholar
  36. Harris PJ (1992) Regulation of proxima tubule function by angiotensin. Clinical and experimental Pharmacology and Physiology 19(4):213PubMedCrossRefGoogle Scholar
  37. Hierholzer K (1986) Diuretika als spezifische Elektrolyttransport-Inhibitoren. In: Knauf H, Mutschier E (Hrsg) Diuretika. Ubran & Schwarzenberg München, S 169–172Google Scholar
  38. Hirsch AT, Dzau VJ, Creager MA (1987) Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. Circulation 75 (Suppl IV):36Google Scholar
  39. Holland OB, Nixon JV, Kuknert L (1981) Diuretic induced ventricular ectopic activity. Am J Med 70:762PubMedCrossRefGoogle Scholar
  40. Hollifield JW (1984) Potassium and magnesium abnormalities: diuretics and arrythmias in hypertension. Am J Med 77 (5A):28PubMedCrossRefGoogle Scholar
  41. Hostetter TH, Pfeffer JM, Pfeffer MA et al (1983) Cardiorenai hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol 245:H98PubMedGoogle Scholar
  42. Humes HD, Gottlieb M, Brenner BM (1978) The kidney in congestive hart failure. In: Brenner BM, Stein JH (eds) Contemporary issues in nephrology. (vol 1) Curchill Livingstone, New York S 51Google Scholar
  43. Ichikawa I, Brenner BM (1980) Importance of efferent arteriolar vascular tone in regulation of proximale tubule fluid reab-sorption and glomerulo-tubular balance in the rat. J Clin Invest 65:1192PubMedCrossRefGoogle Scholar
  44. Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM (1984) Role of angiotensin II in the altered renal of congestive heart failure. Circ Res 55:669PubMedGoogle Scholar
  45. Inove M, Okajima K, Itoh K et al (1987) Mechanism of furosemide resistance in analbuminemic rat and hypoalbuminmic patients. Kidney Int 32:198CrossRefGoogle Scholar
  46. Johnston GD, Hiatt WR, Nies AS et al (1983) Factors modifying the early nondiuretic vascular effects of frusemide in man. Circ Res 53:630PubMedGoogle Scholar
  47. Karim A (1978) Parmacokinetics and metabolism of aldosterone antagonists. In: Addison GM et al (eds) Aldosterone antagonists in clin. medicine. Excerpta Medica, Amsterdam, p 115Google Scholar
  48. Kawaga CM (1964) Anti-aldosterons. In: Dorfman RJ (ed) Methods in hormone research. Academic Press, New York, p 351Google Scholar
  49. Keeler R (1974) Natriuresis after unilateral stimulation of carotid receptors in unanesthetized rats. AM J Physiol 226:507PubMedGoogle Scholar
  50. Kiyingi A, Field MJ, Pawsey CC et al (1970) Metolazone in treatment of severe refractory congestive cardiac failure. Lancet 335:29CrossRefGoogle Scholar
  51. Knauf H, Wais U, Albiez G, Lübcke R (1976) Hemmung des Austausches von Na+ gegen K+ und H+ durch Triamteren (in Epithelien). Arzneim Forsch 26:484Google Scholar
  52. Knauf H, Mutschier E (1984) Pharmacodynamics and pharmacokinetics of xipamid in patients with normal and impaired kidney function. Eur J Clin Pharmacol 26:513PubMedCrossRefGoogle Scholar
  53. Knauf H, Mutschier E (1991) Pharmcodynamic and kinetic consideration on diuretics as a basis for differential therapy. Klin Wschr 69:239PubMedCrossRefGoogle Scholar
  54. Knauf H, Mutschier E (1992) Das Wirkprofil von Diuretika. Internist 33 (Suppl):16Google Scholar
  55. König B, Ricapito S, Kinne R (1983) Chloride transport in the thick ascending limb of Henle loop; potassium dependence and stoichiometry of the NaCl cotransport system in the plasma membrane vesicles. Pflügers Arch 399:173CrossRefGoogle Scholar
  56. Kramer H, Heppe M, Weiler E et al (1985) Further characterisation of the endogenous natriuretic and digoxin-like immunoreacting activities in human urine: effects of changes in sodium intake. Renal Physiol 8:80PubMedGoogle Scholar
  57. Kröger N, Szuba J, Frenzel H (1991) Metolazone in der Behandlung fortgeschrittener therapieresistenter dilatativer Kardiomyopathien. Med Klin 86:305Google Scholar
  58. Lee WH, Packer M (1986) Prognostic significance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 67:257CrossRefGoogle Scholar
  59. Levy M (1972) Effects of acute volume expansion and altered hemodynamics on the renal tubular function in chronic cavai dogs. J Clin Invest 51:922PubMedCrossRefGoogle Scholar
  60. Lloyd-Mostyn RH, Lord IJ (1971) Ototoxicity of intravenous frusemide. Lancet 11:1156CrossRefGoogle Scholar
  61. Medical Research Council Working Party: MRC Trial of mild hypertension: principal results. Br Med J 291:97Google Scholar
  62. Meng K, Kroneberg G (1965) Untersuchungen an der Ratte zur Frage der diabetogenen Wirkung von Saluretika. Naunyn Schmiedebergs, Arch exp Pathol Pharmacol 251:433CrossRefGoogle Scholar
  63. Meng K (1970) Zum renalen Wirkmechanismus der Diuretika. Dtsch med Wschr 95:2089PubMedCrossRefGoogle Scholar
  64. Myers BD, Deen WM, Brenner BM (1975) Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101PubMedGoogle Scholar
  65. Neaton JD et al (1993) Treatment of Mild Hypertension Study. JAMA Vol 270, No 6Google Scholar
  66. Podrid PJ (1990) Potassium and ventricular arrhythmias. Am J Cardiol 65:33EPubMedCrossRefGoogle Scholar
  67. Packer M, Medina N, Yushak M (1984) Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Ann int med 100:782PubMedGoogle Scholar
  68. Pollare T (1990) Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE-inhibi-tion. J Diab Compi 4:75Google Scholar
  69. Priebe HJ, Heimann JC, Hedley-White J (1980) Effects of renal and hepatic venous congestion on renal function in the presence of low and normal cardiac outputs in dogs. Circ Res 47:883PubMedGoogle Scholar
  70. Raine AEG, Erne P, Burgisser E et al (1986) Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315:533PubMedCrossRefGoogle Scholar
  71. Riegger GAJ, Eisner D, Kromer EP et al (1988) Atrial natriuretic peptide in congestive heart failure in the dog. Circulation 77:398PubMedCrossRefGoogle Scholar
  72. Rose HJ, Pruitt AW, Dayton PG, McNay JL (1976) Relationship of urinary furosemide excetion rate to natriuretic effects in experimental azotemia. J Pharmacol exp Ther 199:490PubMedGoogle Scholar
  73. Saccomani E, Mitchell KD, Navav LG (1990) Angiotensin II stimulation of Na+/H+ exchange in proximal tuble cells. Am J Physiol 258:1188Google Scholar
  74. Schlatter E, Salomonsson M, Persson AEG, Greger R (1989) Macula densa cells sense luminal NaCl-concentration via furosemide sensitive Na-2C1-K cotransporter. Pflügers Arch 414:286PubMedCrossRefGoogle Scholar
  75. Schrier RW (1988) Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephritic syndrome, cirrhosis and pregnancy. N Engl J Med 319 No 16:1065Google Scholar
  76. Schwartz GJ, Burg M (1978) Mineralcorticoid effects on cation transport by cortical collecting tubules in vitro. Am J Physiol 235:F576PubMedGoogle Scholar
  77. Scriven TA, Burnett JC (1985) Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure. Circulaton 72:892CrossRefGoogle Scholar
  78. Sigurd B, Olesen K, Wennerold H (1975) The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Am Heart J 89:163PubMedCrossRefGoogle Scholar
  79. Simpson IA, Rae AP, Simpson K et al (1986) Ultrafiltration in teh management of refractory congestive heart failure. Br Heart J 55:344PubMedCrossRefGoogle Scholar
  80. Sklar AH, Schrier PW (1983) Central nervous system mediators of vasopressin release. Physiol Rev 63:1243PubMedGoogle Scholar
  81. Skorecki KL, Brenner BM (1982) Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. Am J Med 72:323PubMedCrossRefGoogle Scholar
  82. SOLVD-Investigators (1991) Effect of enalapril on survival in patients reduced left ventricular ejections fractions and congestive heart failure. N Engl J Med 325:293CrossRefGoogle Scholar
  83. Stokes JB, Kokko JP (1977) Inhibition of sodium transport by prostaglandin E2 across the isolated perfused rabbit colleting tubule. J Clin Invest 59:1099PubMedCrossRefGoogle Scholar
  84. Suki WN, Hull AR, Rector FC, Seidin DW (1967) Mechanism of the effect of thiazide diuretics on calcium and uric acid. J clin Invest 46:1126Google Scholar
  85. Yrhames MD, Peterson MG, Schmid PG (1980) Stimulation of cardiac receptors with veratrum alkaloids inhibits ADH secretion. Am J Physiol 239:H784Google Scholar
  86. Trhurau K (1966) Influence of sodium concentration at macula densa cells on tubular sodium load. Ann NY Acad Sci 139:388CrossRefGoogle Scholar
  87. Vasko MB, Brown-Cartwright D, Knochel JP et al (1985) Furosemid absorption altered in decompesnsated congestive heart failure. Ann intern Med 102:314PubMedGoogle Scholar
  88. Willarreal D, Freeman RH, Davis JO, Verburg KM, Vari RC (1987) Atrial natriuretic factor secretion in dogs with experimental high-output heart failure. Am J Physiol 252: H692Google Scholar
  89. Warner GF, Dobson EL, Rodgers CE, Johnston ME, Pace N (1952) Measurement of total “sodium space” and total body sodium in normal individuals and in patients with cardiac edema. Circulation 5:915PubMedGoogle Scholar
  90. Watkins L, Burton JA, Haber E, Cant JP, Smith FW, Barger AC (1976) The renin-angiotensin-aldosterone system in congestive heart failure in conscious dogs. J Cln Invest 57:1606CrossRefGoogle Scholar
  91. Wilcox CS, Mitch WE, Kelly RA, Skorecki K et al (1983) Response of the kidney to furosemide. I. Effect of salt intake and renal compensation. J Lab clin Med 102:450PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • N. Kröger
  • H. Frenzel

There are no affiliations available

Personalised recommendations